Updated September 2026Offer on the homepage, none on the productAlinwell review
A GLP-1 service for women whose homepage advertises a new-patient offer, while both product pages say the price is set at consultation.
The verdict
Alinwell's homepage runs a new-patient offer: semaglutide from $149 a month and tirzepatide from $199. Its own semaglutide and tirzepatide pages print no price at all, only "Available by consultation". No standing monthly rate is published for either molecule.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Alinwell sells compounded semaglutide and tirzepatide by injection, marketed to women, plus a microdose program. The site runs the same compiled application as seven other GLP-1 brands, down to the testimonial photographs. Each brand configures its own products and prices inside that shared software.
Who writes the prescription, and what do they see?
The site says licensed providers review each patient's health and make every dosing decision. It does not name a clinician, a medical group or a state license. A patient who is not approved pays nothing, per the homepage.
The program page lists a dedicated provider, portal messaging and structured check-ins. Medication ships from partner compounding pharmacies in temperature-controlled packaging. The FAQ says no long-term commitment is required. Service is stated as available in all 50 states.
What happens when the dose goes up?
The semaglutide page describes titration in month one and a therapeutic dose by month three. It cites trial averages, not Alinwell patients. No milligram schedule is published, and nothing says whether the monthly charge changes with dose.
What the price includes
The two homepage figures carry the words "from" and sit under a new-patient banner. The footer adds "Plans from $149/mo · confirmed after provider review". The product pages, which would normally carry the binding figure, defer to the consultation. A reader cannot tell from the site what month two costs.
What it claims, and what it cites
Both molecules are compounded. The homepage states that compounded semaglutide and tirzepatide are not FDA-approved and are not the same as the branded medications. Certificates of analysis are posted for several batches, with the vial concentration. The pharmacies themselves are not named.
Where it holds up, and where it does not
- Strength: Batch certificates of analysis are published
- Strength: Compounded status is stated plainly
- Strength: No charge if a patient is not approved
- Strength: No long-term commitment required
- Limitation: Product pages print no price
- Limitation: Homepage figures are a new-patient offer
- Limitation: Shares one build with seven other brands
- Limitation: No clinician or pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Alinwell. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A woman who wants a provider-led compounded program and will get the post-consultation price in writing.
- Wrong for
- A reader who needs a published standing rate to compare before starting an intake.
How Alinwell compares
| Seller | Who it suits | Go |
|---|---|---|
 Hers | Readers who want a wide catalog and will budget the membership as the main charge | See Hers → |
 ElleS | Buyers who want the prescribing physicians and pharmacies named before they pay | See ElleS → |
 Midi Health | Readers who want every rung costed, with its milligram, before choosing a first dose | See Midi Health → |
More GLP-1 telehealth sellers reviews: ARSYNL RxAscend MedicalAscend VitalityAskRxAspenAspire Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $149 the monthly price of semaglutide?
- It is the homepage's new-patient offer. The semaglutide page itself reads "Available by consultation", so the standing rate is not published.
- Is Alinwell a separate company from other GLP-1 sites?
- It is its own brand, but the site runs the same compiled application as seven other GLP-1 brands. Each sets its own products and prices within it.
- Does Alinwell publish lab results for its medication?
- It posts certificates of analysis for named batches, showing concentration and test month. It does not name the pharmacy.